Is Sangani Hospital overvalued or undervalued?

As of 5 September 2025, Sangani Hospital's valuation grade has moved from attractive to fair, indicating a shift in its perceived value. The company is currently fairly valued based on its financial ratios, with a PE ratio of 38.03, an EV to EBITDA of 32.28, and a ROCE of 12.91%. Compared to its peers, Apollo Hospitals, which is rated attractive, has a significantly higher PE ratio of 71.31, while Narayana Hrudaya is considered expensive with a PE of 46.06.
Given the current valuation metrics and the peer comparison, Sangani Hospital appears to be fairly valued. The company's recent stock performance has outpaced the Sensex, with a 1-year return of 63.62% compared to the Sensex's -1.61%, reinforcing the notion that while it is fairly valued, it has been a strong performer in the market.